CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	1 Months Ended	5 Months Ended	6 Months Ended
	Sep. 27, 2012	Aug. 30, 2012 Predecessor	Sep. 29, 2011 Predecessor
Cash flows from operating activities:
Net earnings (loss)	$ (43,043)	$ 94,400	$ (9,938)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	16,602	81,234	103,171
Theatre and other closure expense	434	11,753	4,066
Gain on dispositions	(74)	(48,245)
Equity in earnings and losses from non-consolidated entities, net of distributions	3,421	(495)	14,553
Change in assets and liabilities:
Receivables	2,773	11,766	(4,461)
Other assets	(31,618)	36,770	(2,538)
Accounts payable	12,814	(58,027)	(6,695)
Accrued expenses and other liabilities	8,226	(50,473)	13,270
Other, net	(1,660)	814	(3,687)
Net cash provided by (used in) operating activities	(32,125)	79,497	107,741
Cash flows from investing activities:
Capital expenditures	(10,638)	(40,116)	(56,508)
Merger	3,110
Proceeds from sale/leaseback of digital projection equipment			953
Investments in non-consolidated entities, net	(13)	1,589	(21,699)
Proceeds from the disposition of long-term assets	107	7,291	801
Other, net	(442)	205	(237)
Net cash used in investing activities	(7,876)	(31,031)	(76,690)
Cash flows from financing activities:
Repurchase of Senior Subordinated Notes due 2014		(191,035)
Deferred financing costs		(2,378)	(585)
Principal payments under capital and financing lease obligations	(222)	(1,298)	(1,869)
Principal payments under Term Loan		(4,002)	(1,625)
Capital contribution	100,000
Change in construction payables	(1,245)	(23,575)	(4,194)
Net cash provided by (used in) financing activities	98,533	(222,288)	(8,273)
Effect of exchange rate changes on cash and equivalents	(389)	16	853
Net increase (decrease) in cash and equivalents	58,143	(173,806)	23,631
Cash and equivalents at beginning of period	98,531	272,337	301,158
Cash and equivalents at end of period	$ 156,674	$ 98,531	$ 324,789